In Law360, Cross-Office Team Analyzes President Trump’s Drug Pricing Plan
Partner Tom Bulleit (Washington, D.C.) co-authored a May 17 article in Law360 analyzing the Trump administration’s four-point plan for curbing prescription drug prices.
The authors break down the administration’s key proposals and likely paths forward, including assessing whether potential changes could be made quickly by administrative action, or are more likely to take more time and require legislation.